SFRP1 and breast hyperplasia: These results are also in concordance with the study of Gregory et al., in which the authors reported that breast hyperplasia samples expressed less SFRP1 than paired benign tissue, as well as that treatment of human breast explant cultures with E2 + recombinant SFRP1 decreased the response to E2 compared to treatment with E2 alone [48].